China NMPA Product Recall - CONTOUR NEXT GEN meter

Ascensia Diabetes Care Holdings AG has initiated a voluntary Class II recall of its CONTOUR NEXT GEN blood glucose meters. This action, reported by Shanghai Jianzhen Medical Technology Co., Ltd. and published by the National Medical Products Administration (NMPA) on July 10, 2025, addresses an identified issue where the device displays an incorrect unit setting in its readings. While specific models, specifications, and batch details are available in an attached recall report, it is important to note that the products involved in this recall were not imported into China. The recall signifies the company's commitment to product safety and regulatory compliance, addressing a potential accuracy concern for users of the CONTOUR NEXT GEN meter.